Hospital Medicine Alert – June 1, 2007
June 1, 2007
View Issues
-
Selenium and Sepsis: It's Not Your Average Once-a-Day Vitamin
A prospective randomized, placebo-controlled, multi-center trial demonstrates that a prolonged course of intravenous selenium improves mortality in patients with severe sepsis and septic shock and is associated with minimal to no side effects. -
Revised Empiric Treatment IDSA/ATS Guidelines for CAP
Since the publication of the initial IDSA Guidelines for the Management of Community-Acquired Pneumonia in 2003, hospital administrators have been scrambling to improve their numbers. -
What is the Optimal Dosing for Unfractionated Heparin?
Unfractionated heparin (UH) is commonly used in acutely ill hospital patients at risk for venous thromboembolism (VTE). -
What Happens To Removable Vena Cava Filters?
Among 413 patients who underwent placement of a removable inferior vena cava filter following trauma for prophylaxis or treatment of pulmonary thromboembolism and survived to hospital discharge, subsequent removal of the filter was attempted in 116 of them and successful in only 91 (22%). -
IVIG for Myasthenia Gravis and Miller Fisher Syndrome
IVIG is safe and effective for worsening Myasthenia Gravis, but has no effect on the natural course of Miller Fisher syndrome. -
MRSA in Dialysis Patients
The incidence of invasive infections due to MRSA in 2005 was approximately 100 times greater in chronic dialysis patients than in the general population.